Shopping Cart
- Remove All
- Your shopping cart is currently empty
Polmacoxib (CG 100649) is a first-in-class NSAID drug candidate, is a dual inhibitor of carbonic anhydrase (CA) and COX-2. Polmacoxib inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $39 | In Stock | |
5 mg | $64 | In Stock | |
10 mg | $109 | In Stock | |
25 mg | $183 | In Stock | |
50 mg | $272 | In Stock | |
100 mg | $397 | In Stock | |
200 mg | $593 | In Stock | |
1 mL x 10 mM (in DMSO) | $70 | In Stock |
Description | Polmacoxib (CG 100649) is a first-in-class NSAID drug candidate, is a dual inhibitor of carbonic anhydrase (CA) and COX-2. Polmacoxib inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation. |
Targets&IC50 | COX-2:0.1 μg/mL (IC50) |
Alias | CG-100649, CG100649, CG 100649 |
Molecular Weight | 361.39 |
Formula | C18H16FNO4S |
Cas No. | 301692-76-2 |
Smiles | CC1(C)OC(=C(C1=O)c1cccc(F)c1)c1ccc(cc1)S(N)(=O)=O |
Relative Density. | 1.361 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | H2O: Insoluble DMSO: 55 mg/ml (152.19 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.